Sysmex Co. (OTCMKTS:SSMXY – Get Rating) was the target of a significant growth in short interest during the month of January. As of January 15th, there was short interest totalling 40,700 shares, a growth of 498.5% from the December 31st total of 6,800 shares. Based on an average trading volume of 86,400 shares, the short-interest ratio is currently 0.5 days.
Sysmex Price Performance
SSMXY traded down $0.46 on Friday, reaching $32.76. The company had a trading volume of 21,578 shares, compared to its average volume of 34,821. The company has a fifty day moving average of $31.07 and a 200-day moving average of $30.18. The company has a market capitalization of $13.74 billion, a P/E ratio of 37.94 and a beta of 0.61. The company has a current ratio of 2.88, a quick ratio of 2.07 and a debt-to-equity ratio of 0.05. Sysmex has a one year low of $25.08 and a one year high of $49.94.
Get
Sysmex alerts:
Sysmex (OTCMKTS:SSMXY – Get Rating) last announced its earnings results on Wednesday, November 9th. The company reported $0.28 earnings per share (EPS) for the quarter. The firm had revenue of $782.19 million during the quarter. Sysmex had a net margin of 11.70% and a return on equity of 12.51%. As a group, equities research analysts anticipate that Sysmex will post 0.92 earnings per share for the current year.
About Sysmex
(Get Rating)
Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing.
Read More
- Get a free copy of the StockNews.com research report on Sysmex (SSMXY)
- Why Lucid Spiked Nearly 100% In One Day
- Ride These Railroad Stocks for Growth and Income
- ASML Sees Demand For Chips Rallying This Year, Boosts Sales View
- KLA Corporation: Strength In A Troubled Semi-Market
- PCE Indicates Slowdown In Spending, Economy Weakens
Receive News & Ratings for Sysmex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sysmex and related companies with MarketBeat.com's FREE daily email newsletter.
Sysmex Co.(场外交易代码：SSMXY-GET Rating)是空头股数在1月份实现显著增长的目标。截至1月15日，空头股数共有40,700股，较12月31日的6,800股增长498.5%。以平均成交量86,400股计算，目前短息比为0.5天。
Sysmex性价比
上周五，SSMXY股价下跌0.46美元，至32.76美元。该公司的成交量为21,578股，而其平均成交量为34,821股。该公司的50日移动均线切入位在31.07美元，200日移动均线切入位在30.18美元。该公司市值为137.4亿美元，市盈率为37.94倍，贝塔系数为0.61。该公司的流动比率为2.88，速动比率为2.07，债务权益比率为0.05。Sysmex的一年低点为25.08美元，一年高位为49.94美元。
到达
Sysmex警报：
Sysmex(OTCMKTS：SSMXY-GET Rating)上一次公布收益业绩是在11月9日星期三。该公司公布该季度每股收益(EPS)为0.28美元。该公司本季度的收入为7.8219亿美元。Sysmex的净利润率为11.70%，股本回报率为12.51%。作为一个整体，股票研究分析师预计Sysmex本年度每股收益将为0.92美元。
关于Sysmex
(获取评级)
Sysmex Corp.从事医疗保健业务。它开发、制造、销售、出口和进口诊断仪器、试剂。以及用于体外诊断的软件。它还提供血液、尿液和其他标本的临床实验室检测。其产品包括止血、免疫化学、临床化学、尿液分析和护理点(POC)测试的仪器和试剂诊断。
阅读更多内容
- 免费获取关于Sysmex(SSMXY)的StockNews.com研究报告
- 为什么Lucid在一天内飙升了近100%
- 利用这些铁路股票实现增长和收入
- ASML预计今年芯片需求回升，提振销售观点
- KLA公司：在动荡不安的半市场中站稳脚跟
- PCE表明支出放缓，经济疲软
接受Sysmex Daily的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Sysmex和相关公司的最新新闻和分析师评级的每日简要摘要。
